Fil de navegació
Patologia molecular en neoplàsies limfoides
Publicacions destacades
-
Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints
Gonzalez-Farre, Blanca; Ramis-Zaldivar, Joan E; Castrejon de Anta, Natalia; Rivas-Delgado, Alfredo; Nadeu, Ferran;(...)Lopez-Guerra, Monica; Quintanilla-Martinez, Leticia; Lopez-Guillermo, Armando; Salaverria, Itziar; Campo, Elias.Referència:American Journal Of Surgical Pathology 2023.
-
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee
Campo, E; Jaffe, ES; Cook, JR; Quintanilla-Martinez, L; Swerdlow, SH;(...)Zinzani, PL; Dreyling, M; Scott, DW; Winter, JN; Zelenetz, A.Referència:Blood 2022.
-
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nadeu, Ferran; Royo, Romina; Massoni-Badosa, Ramon; Garcia-Torre, Beatriz; Duran-Ferrer, Marti;(...)Capella-Gutierrez, Salvador; Li Gelp, Josep; Lopez-Bigas, Niiria; Garcia-Roves, Pablo M; Martin-Subero, Jose, I.Referència:Nature Medicine 2022.
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Giné, E; de la Cruz, F; Ubieto, AJ; Jimenez, JL; García-Sancho, AM;(...)Sanz, RG; Nadeu, F; Beà, S; Campo, E; López-Guillermo, A.Referència:Journal Of Clinical Oncology 2022.
-
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Nadeu, F; Royo, R; Clot, G; Duran-Ferrer, M; Navarro, A;(...)Jares, P; Puente, XS; Martín-Subero, JI; Delgado, J; Campo, E.Referència:Blood 2021.
-
A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma
Demajo, S; Albero, R; Clot, G; Castellano, G; Navarro, A;(...)Rimsza, LM; López-Guillermo, A; Beà, S; Campo, E; Jares, P.Referència:Clinical Cancer Research 2021.
-
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Nadeu, F; Mas-de-les-Valls, R; Navarro, A; Royo, R; Martin, S;(...)Puente, XS; Campbell, PJ; Bea, S; Maura, F; Campo, E.Referència:Nature Communications 2020.
-
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma
Martin-Garcia, David; Navarro, Alba; Valdes-Mas, Rafael; Clot, Guillem; Gutierrez-Abril, Jesus;(...)Lopez-Otin, Carlos; Salaverria, Itziar; Puente, Xose S; Campo, Elias; Bea, Silvia.Referència:Blood 2019.
-
Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas
Roisman, Alejandro; Castellano, Giancarlo; Navarro, Alba; Gonzalez-Farre, Blanca; Perez-Galan, Patricia;(...)Lopez-Guillermo, Armando; Jares, Pedro; Martin-Subero, Jose, I; Campo, Elias; Hernandez, Luis.Referència:British Journal Of Haematology 2019.
-
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
Clot, Guillem; Jares, Pedro; Gine, Eva; Navarro, Alba; Royo, Cristina;(...)Rosenwald, Andreas; Scott, David W; Rimsza, Lisa M; Bea, Silvia; Campo, Elias.Referència:Blood 2018.